Ignite Creation Date:
2025-12-24 @ 1:04 PM
Ignite Modification Date:
2025-12-30 @ 2:26 AM
Study NCT ID:
NCT07214961
Status:
RECRUITING
Last Update Posted:
2025-12-22
First Post:
2025-07-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Alpha Radioligand Therapy AB001 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
Sponsor:
ARTBIO Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-11-03
Start Date Type:
ACTUAL
Primary Completion Date:
2027-11-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-11-03
Completion Date Type:
ESTIMATED
First Submit Date:
2025-07-21
First Submit QC Date:
None
Study First Post Date:
2025-10-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-19
Last Update Post Date:
2025-12-22
Last Update Post Date Type:
ESTIMATED